Estados financieros detallados de Incannex Healthcare Limited (IXHL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Incannex Healthcare Limited registró ingresos de $86000 en el último ejercicio fiscal, con un CAGR de 5 años del -32.2%.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $91688 | $283015 | $1.0M | $1.2M | $599722 | $1.9M | $785151 | 0 | $12000 | $86000 |
| Coste de Ventas | $303331 | $518275 | $522833 | $583188 | $446502 | $913257 | $6335 | 0 | $103000 | $246000 |
| Beneficio Bruto | -$213893 | -$235260 | $486993 | $597260 | $153219 | $987019 | $778790 | 0 | $12000 | -$160000 |
| I+D | 0 | 0 | 0 | 0 | 0 | $4.8M | $5.4M | $9.5M | $19.3M | $10.7M |
| Generales y Administrativos | $514057 | $2.7M | $3.6M | $2.6M | $2.2M | $7.7M | $10.2M | $11.9M | $25.6M | $13.1M |
| Gastos Operativos | $506474 | $20.8M | $3.7M | $3.4M | $4.3M | $12.4M | $12.1M | $20.5M | $30.1M | $23.6M |
| Beneficio Operativo | -$658053 | -$21.0M | -$3.2M | -$2.8M | -$4.1M | -$11.4M | -$11.4M | -$20.5M | -$30.0M | -$23.8M |
| EBITDA | -$704753 | -$21.0M | -$3.1M | -$2.7M | -$4.1M | -$11.3M | -$16.5M | -$20.4M | -$27.7M | -$23.5M |
| Gastos por Intereses | $81501 | $49972 | $12852 | $85207 | 0 | 0 | 0 | 0 | 0 | $303000 |
| Beneficio Antes de Impuestos | -$738047 | -$21.1M | -$3.2M | -$2.9M | -$3.9M | -$11.4M | -$14.9M | -$73.5M | -$18.4M | -$48.6M |
| Impuestos | 0 | -$305756 | -$262652 | -$151577 | 0 | 0 | 0 | 0 | $30000 | -$1.8M |
| Beneficio Neto | -$719931 | -$20.8M | -$2.9M | -$2.7M | -$4.7M | -$11.4M | -$14.9M | -$73.5M | -$18.5M | -$46.9M |
| BPA | $-1.41 | $-19.59 | $-1.56 | $-0.74 | $-0.69 | $-1.40 | $-1.50 | $-14.31 | $-3.42 | $-40.80 |
| BPA Diluido | $-1.41 | $-19.59 | $-1.56 | $-0.74 | $-0.69 | $-1.40 | $-1.50 | $-14.31 | $-3.42 | $-40.80 |
| Acciones en Circulación (Diluidas) | $522931 | $1.1M | $1.9M | $3.7M | $5.7M | $8.2M | $9.9M | $5.1M | $5.4M | $1.1M |
Cuenta de Resultados (Trimestral)
| Año | 2024-Q1 | 2024-Q3 | 2025-Q2 | 2025-Q4 |
|---|
| Ingresos | 0 | $108987 | $66616 | 0 |
| Beneficio Bruto | 0 | $108987 | -$128371 | 0 |
| Beneficio Operativo | -$11.4M | -$9.2M | -$18.8M | -$7.0M |
| EBITDA | -$9.3M | -$7.9M | -$39.1M | -$6.5M |
| Beneficio Neto | -$9.3M | -$8.0M | -$35.6M | -$6.5M |
| BPA | $-1.14 | $-0.87 | $-0.69 | $-0.60 |
| BPA Diluido | $-1.14 | $-0.87 | $-0.69 | $-0.60 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $4573 | $508740 | $229582 | $93716 | $3.6M | $9.1M | $37.5M | $33.3M | $5.9M | $15.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $5720 | $8119 | $10475 | $84279 | $409741 | $169326 | $318806 | $287475 | $10.0M | $4.6M |
| Inventario | $58216 | $227406 | $223831 | $153369 | $181596 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $114209 | $842438 | $541891 | $384693 | $4.2M | $9.3M | $38.0M | $34.6M | $16.2M | $20.0M |
| Inmovilizado Material | $24733 | $44198 | $98181 | $85775 | 0 | 0 | 0 | $1.2M | $845000 | $485000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $205994 | $117152 | $71431 | $49580 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $344938 | $1.0M | $711506 | $520049 | $4.2M | $9.3M | $38.0M | $35.8M | $17.0M | $20.4M |
| Cuentas por Pagar | $141916 | $537622 | $497548 | $377676 | $585063 | $232983 | $1.3M | $2.6M | $527000 | $6.1M |
| Deuda a Corto | $698878 | 0 | $201030 | $65268 | 0 | 0 | 0 | 0 | 0 | $184000 |
| Pasivos Corrientes | $1.0M | $774348 | $1.1M | $938952 | $1.1M | $756115 | $2.0M | $3.8M | $5.6M | $7.0M |
| Deuda a Largo | 0 | $398893 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.0M | $1.2M | $1.1M | $938952 | $1.1M | $754620 | $2.0M | $4.5M | $5.8M | $7.1M |
| Reservas | -$809009 | -$22.2M | -$25.2M | -$27.9M | -$32.4M | -$44.0M | -$59.0M | -$138.8M | -$110.7M | -$157.6M |
| Patrimonio Neto | -$700356 | -$169451 | -$385294 | -$418902 | $3.1M | $8.6M | $36.0M | $31.3M | $11.2M | $13.4M |
| Deuda Total | $698878 | $398893 | $201030 | $65268 | 0 | 0 | 0 | $784160 | $373000 | $258000 |
| Deuda Neta | $694305 | -$109847 | -$28552 | -$28448 | -$3.6M | -$9.1M | -$37.5M | -$32.5M | -$5.5M | -$14.8M |
| Capital Circulante | -$931086 | $68090 | -$554909 | -$554259 | $3.2M | $8.6M | $36.0M | $30.8M | $10.6M | $13.0M |
Balance (Trimestral)
| Año | 2024-Q2 | 2024-Q4 | 2025-Q2 | 2025-Q4 |
|---|
| Caja y Equivalentes | $5.9M | $2.1M | $15.0M | $68.9M |
| Activos Totales | $17.0M | $11.1M | $20.4M | $75.0M |
| Pasivos Totales | $5.8M | $10.1M | $7.1M | $1.6M |
| Patrimonio Neto | $11.2M | $965000 | $13.4M | $73.4M |
| Deuda Total | $373000 | $4.1M | $258000 | $163000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$736864 | -$20.4M | -$3.0M | -$2.7M | -$4.7M | -$11.4M | -$14.9M | -$73.5M | -$18.5M | -$46.9M |
| Amortizaciones | $15613 | $18.0M | $57482 | 0 | 0 | 0 | 0 | $132449 | $103000 | $246000 |
| Compensación en Acciones | 0 | $146902 | $69159 | $48050 | $563080 | $599701 | $1.5M | $3.2M | $8.9M | $2.6M |
| Cambio en Capital Circulante | -$93175 | -$208486 | $35312 | $57604 | -$371568 | $5769 | $115706 | -$942196 | -$9.5M | $6.8M |
| Flujo de Caja Operativo | -$643931 | -$2.7M | -$3.0M | -$2.2M | -$3.9M | -$6.9M | -$12.9M | -$16.2M | -$15.8M | -$12.5M |
| Inversiones (CapEx) | -$9295 | -$50304 | -$50086 | -$24542 | 0 | $4 | $5 | -$475613 | -$277000 | -$8000 |
| Adquisiciones | 0 | $3.1M | 0 | 0 | $12574 | $29317 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$653226 | -$2.7M | -$3.0M | -$2.2M | -$3.9M | -$6.9M | -$12.9M | -$16.7M | -$16.1M | -$12.5M |
Flujo de Caja (Trimestral)
| Año | 2024-Q2 | 2024-Q4 | 2025-Q2 | 2025-Q4 |
|---|
| Flujo de Caja Operativo | -$3.6M | -$3.2M | -$1.1M | -$9.1M |
| Inversiones (CapEx) | $3000 | 0 | $56000 | -$62000 |
| Flujo de Caja Libre | -$3.6M | -$3.2M | -$1.0M | -$9.2M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.3M | $417000 | $1.7M | $3.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +208.7% | +256.8% | +16.9% | -49.2% | +216.9% | -58.7% | -100.0% | | +616.7% |
| Crecimiento Beneficio Neto (anual) | | -2784.0% | +85.8% | +7.4% | -71.0% | -144.5% | -30.8% | -393.0% | +74.9% | -154.0% |
| Crecimiento BPA (anual) | | -1289.4% | +92.0% | +52.6% | +6.8% | -102.9% | -7.1% | -854.0% | +76.1% | -1093.0% |
| Cambio en Acciones (anual) | | +103.4% | +78.6% | +96.3% | +52.9% | +43.0% | +21.8% | -48.3% | +5.1% | -78.7% |
| Crecimiento FCF (anual) | | -320.3% | -11.1% | +28.1% | -77.4% | -77.5% | -86.1% | -29.6% | +3.2% | +22.3% |
| Margen Bruto | -233.3% | -83.1% | 48.2% | 50.6% | 25.5% | 51.9% | 99.2% | | 100.0% | -186.0% |
| Margen Operativo | -717.7% | -7429.9% | -317.9% | -236.6% | -685.5% | -601.3% | -1445.7% | | -250341.7% | -27661.6% |
| Margen EBITDA | -768.6% | -7415.7% | -310.6% | -232.7% | -676.7% | -596.9% | -2107.0% | | -230852.8% | -27375.6% |
| Margen Neto | -785.2% | -7336.2% | -291.2% | -230.7% | -776.6% | -599.3% | -1898.0% | | -153825.0% | -54517.4% |
| Margen FCF | -712.4% | -970.0% | -302.0% | -185.9% | -648.8% | -363.4% | -1637.0% | | -134350.0% | -14559.3% |
| Tasa Impositiva Efectiva | -0.0% | 1.5% | 8.2% | 5.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.2% | 3.6% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1.25 | $-2.58 | $-1.61 | $-0.59 | $-0.68 | $-0.85 | $-1.29 | $-3.25 | $-2.99 | $-10.90 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $522931 | $1.1M | $1.9M | $3.7M | $5.7M | $8.2M | $9.9M | $5.1M | $5.4M | $1.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Salud financiera
| Piotroski F-Score | 3 |
| Altman Z-Score | -13.23 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1701.13 | -118.37 | -1545.46 | -3463.34 | -3748.39 | -1700.02 | -447.27 | -23.16 | -25.88 | -0.16 |
| P/VC | -1790.95 | -14554.83 | -11888.53 | -22812.25 | 4699.13 | 2259.24 | 185.01 | 54.21 | 42.51 | 0.55 |
| P/V | 13680.09 | 8714.49 | 4536.00 | 8095.31 | 24583.37 | 10207.74 | 8481.86 | 0.00 | 39736.50 | 86.40 |
| Margen Bruto | -233.3% | -83.1% | 48.2% | 50.6% | 25.5% | 51.9% | 99.2% | 0.0% | 100.0% | -186.0% |
| Margen Operativo | -717.7% | -7429.9% | -317.9% | -236.6% | -685.5% | -601.3% | -1445.7% | 0.0% | -250341.7% | -27661.6% |
| Margen Neto | -785.2% | -7336.2% | -291.2% | -230.7% | -776.6% | -599.3% | -1898.0% | 0.0% | -153825.0% | -54517.4% |